Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001782226-20-000002
Filing Date
2020-12-01
Accepted
2020-12-01 12:06:03
Documents
1
Effectiveness Date
2020-12-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7317
  Complete submission text file 0001782226-20-000002.txt   8337
Mailing Address 13250 VIA ARRIBA DRIVE SARATOGA CA 95070
Business Address 13250 VIA ARRIBA DRIVE SARATOGA CA 95070 408-476-1904
i2O Therapeutics, Inc. (Filer) CIK: 0001782226 (see all company filings)

IRS No.: 841743853 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-381826 | Film No.: 201360295